Journals / Turkish Journal of Pharmaceutical Sciences / 2018 / Cilt: 15 - Sayı: 3

Antimicrobial Activities of New Indole Derivatives Containing 1,2,4-Triazole, 1,3,4-Thiadiazole and Carbothioamide

1,2,4-Triazol, 1,3,4-Tiyadiazol ve Karbotiyoamit İçeren Yeni İndol Türevlerinin Antimikrobiyal Aktiviteleri

Pages
291–297
Publication Date
2022-11-04
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Thisstudy provides valuable evidence that the indole-triazole derivative compound 3d holds significant promise as a novel antibacterial and antifungallead compound

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: In new antimicrobial drug development studies, indole and its derivatives create an important class of compounds.
📊
Key Findings & Data:In this studyantimicrobial activities of some indole derivatives mainly substituted with 1,2,4-triazole, 1,3,4-thiadiazole and hydrazinecarbothioamide wereinvestigated to evaluate their efficacy.Materials and Methods: The efficacy of new compounds was evaluated using 2-fold serial dilutions against Staphylococcus aureus, MRSA, Escherichiacoli, Bacillus subtilis, Candida albicans, and Candida krusei.Results: The MIC was determined for test compounds and for the reference standards sultamicillin, ampicillin, fluconazole, and ciprofloxacin.Conclusion: The compounds possessed a broad spectrum of activity having MIC values of 3.125-50 µg/mL against the tested microorganisms.
💡
Conclusion & Impact:Thisstudy provides valuable evidence that the indole-triazole derivative compound 3d holds significant promise as a novel antibacterial and antifungallead compound
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: In new antimicrobial drug development studies, indole and its derivatives create an important class of compounds. In addition, azolesand their derivatives were recognized to be associated with a variety of biologic activities such as antibacterial and antifungal. In this studyantimicrobial activities of some indole derivatives mainly substituted with 1,2,4-triazole, 1,3,4-thiadiazole and hydrazinecarbothioamide wereinvestigated to evaluate their efficacy.Materials and Methods: The efficacy of new compounds was evaluated using 2-fold serial dilutions against Staphylococcus aureus, MRSA, Escherichiacoli, Bacillus subtilis, Candida albicans, and Candida krusei.Results: The MIC was determined for test compounds and for the reference standards sultamicillin, ampicillin, fluconazole, and ciprofloxacin.Conclusion: The compounds possessed a broad spectrum of activity having MIC values of 3.125-50 µg/mL against the tested microorganisms. Thisstudy provides valuable evidence that the indole-triazole derivative compound 3d holds significant promise as a novel antibacterial and antifungallead compound

Özet

Amaç: Yeni antibakteriyel ilaç geliştirilme çalışmalarında indol ve türevleri önemli bir bileşik sınıfı oluşturmaktadır. Ayrıca azoller ve türevlerinin antibakteriyel ve antifungal gibi biyolojik aktivite gösterdikleri dikkat çekmektedir. Bu çalışmada 1,2,4-triazol, 1,3,4-tiyadiazol ve hidrazinkarbotiyoamid ile sübstitüe edilmiş indol türevi yeni bileşiklerin, antimikrobiyal etkinlikleri araştırılarak değerlendirilmiştir. Gereç ve Yöntemler: Yeni bileşiklerin antimikrobiyal etkinlikleri, 2-kat seri dilüsyon yöntemi kullanılarak, Staphylococcus aureus, MRSA, Escherichia coli, Bacillus subtilis, Candida albicans ve Candida krusei’ye karşı araştırılarak değerlendirilmiştir. Bulgular: Yeni sentezlenen bileşiklerin MİK, sultamisilin, ampisilin, flukonazol ve siprofloksasin gibi standart referans bileşiklere karşı belirlenmiştir. Sonuç: Bileşikler test edilen mikroorganizmalara karşı 3.125-50 µg/mL gibi geniş spektrum aralığında MİK değerleri göstermişlerdir. Bu çalışmada değerli veriler elde edilmiş ve indol-triazol türevi olan 3d bileşiği antibakteriyel ve antifungal lider bileşik olarak ileri çalışmalar için gelecek vaad etmektedir

🔖

Cite This Article

ALTANLAR, N., SÜZEN, S., SHIRINZADEH, H., WESTWELL, A. D. (2022). Antimicrobial Activities of New Indole Derivatives Containing 1,2,4-Triazole, 1,3,4-Thiadiazole and Carbothioamide. Turkish Journal of Pharmaceutical Sciences, Cilt: 15 - Sayı: 3, 291–297. https://ajindex.com/articles/612468

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Cerniglia CE, Pineiro SA, Kotarski SF. An update discussion on the current assessment of the safety of veterinary antimicrobial drug residues in food with regard to their impact on the human intestinal microbiome. Drug Test Anal. 2016;8:539-548.
  2. Hahn AW, Jain R, Spach DH. New Approaches to antibiotic use and review of recently approved antimicrobial agents. Med Clin North Am. 2016;100:911-926.
  3. Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, Kaplan SL, Karchmer AW, Levine DP, Murray BE, J Rybak M, Talan DA, Chambers HF. Clinical practice guidelines by the infectious diseases society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis. 2011;52:18-55.
  4. Kaku N, Morinaga Y, Takeda K, Kosai K, Uno N, Hasegawa H, Miyazaki T, Izumikawa K, Mukae H, Yanagihara K. Antimicrobial and immunomodulatory effects of tedizolid against methicillin-resistant Staphylococcus aureus in a murine model of hematogenous pulmonary infection. Int J Med Microbiol. 2016;306:421-428.
  5. Al-Qawasmeh RA, Huesca M, Nedunuri V, Peralta R, Wright J, Lee Y, Young A. Potent antimicrobial activity of 3-(4,5-diaryl-1H-imidazol-2- yl)-1H-indole derivatives against methicillin-resistant Staphylococcus aureus. Bioorg Med Chem Lett. 2010;20:3518-3520.
  6. Lepri S, Buonerba F, Goracci L, Velilla I, Ruzziconi R, Schindler BD, Seo SM, Kaatz, GW, Cruciani G. Indole based weapons to fight antibiotic resistance: a structure-activity relationship study. J Med Chem. 2016;59:867-891.
  7. Costa SS, Viveiros M, Amaral L, Couto I. Multidrug Efflux Pumps in Staphylococcus aureus: an Update. Open Microbiol J. 2013;7:59-71.
  8. Deng X, Sun F, Ji Q, Liang H, Missiakas D, Lan L, He C. Expression of multidrug resistance efflux pump gene NorA is iron responsive in Staphylococcus aureus. J Bacteriol. 2012;194:1753-1762.
  9. Markham PN, Westhaus E, Klyachko K, Johnson ME, Neyfakh AA. Multiple novel inhibitors of the NorA multidrug transporter of Staphylococcus aureus. Antimicrob Agents Chemother. 1999;43:2404-2408.
  10. Ambrus JI, Kelso MJ, Bremner JB, Ball AR, Casadei G, Lewis K. Structure-activity relationships of 2-aryl-1h-indole inhibitors of the nora efflux pump in Staphylococcus aureus. Bioorg Med Chem Lett. 2008;18:4294-4297.
  11. Hequet A, Burchak ON, Jeanty M, Guinchard X, Le Pihive E, Maigre L, Bouhours P, Schneider D, Maurin M, Paris JM, Denis JN, Jolivalt C. 1-(1H-Indol-3-yl)ethanamine derivatives as potent Staphylococcus aureus NorA efflux pump Inhibi